Intravenous pharmaceutical form of administration

Details Intravenous pharmaceutical form of administration Intravenous pharmaceutical form of administration

2005-01-27

2010-11-23

Peselev, Elli (Department: 1623)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

Reexamination Certificate

active

07838034

ABSTRACT:
The invention relates to an intravenous pharmaceutical form of administration including undissolved active ingredient parts, and to a kit containing the constituents for producing one such form of administration.

REFERENCES:
patent: 5091188 (1992-02-01), Haynes
patent: 5510118 (1996-04-01), Bosch et al.
patent: 5654008 (1997-08-01), Herbert et al.
patent: 5785976 (1998-07-01), Westesen et al.
patent: 6306366 (2001-10-01), Heldmann et al.
patent: 6337092 (2002-01-01), Khan et al.
patent: 36 23 376 (1988-01-01), None
patent: 37 42 473 (1988-07-01), None
patent: 44 40 337 (1996-05-01), None
patent: 0 161 445 (1985-11-01), None
patent: 0 209 403 (1987-01-01), None
patent: 0 499 299 (1992-01-01), None
patent: WO 91/14455 (1991-10-01), None
patent: WO 96/11669 (1996-04-01), None
patent: WO 99/00113 (1999-01-01), None
“Acetaminophen”. Dictionary.com. Online. Internet. Accessed on Jun. 21, 2005. <http://www.dictionary.reference.com/search?db=mwmed&q=acetaminophen.
“Intravenous”. Thesaurus.com. Online. Internet. Accessed on Jun. 21, 2005. <http://www.thesaurus.reference.com/search?q=intravenous.
“Absolute Bioavailability of Paracetamol after Oral or Rectal Administration in Healthy Volunteers”, M. Eandi, et al., Arzneimittel-Forschung, Drug Research, vol. 34, No. 8, Aug. 1984, pp. 903-907.
“Nanosuspensions for the formulation of poorly soluble drugs I. Preparation by a size-reduction technique”, Rainer H. Muller, et al., International Journal of Pharmaceutics 160 (1998) 229-237.
“Nanosuspensions—A Novel Formulation for the I.V. Administration of Poorly Soluble Drugs”, R.H. Muller, et al., Proc. 1stWorld Meeting APGI/APV, Budapest, May 9/11, 1995, 491-492.
“Preparation of a clofazimine nanosuspension for intraveneous use and evaluation of its therapeutic efficacy in murineMycobacterium aviuminfection”, K. Peters, et al., Journal of Antimicrobial Chemotherapy (2000) 45, 77-83.
“Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide”, C. Jacobs, et al., International Journal of Pharmaceutics 196 (2000) 161-164.
“Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs”, E. Merisko-Liversidge, et al., Pharmaceutical Research, vol. 13, No. 2, 1996, 272-278.
“Hydrosols—Alternatives for the Parenteral Application of Poorly Water Soluble Drugs”, Peter Gabmann, et al., Eur. J. Pharm. Biopharm. 40 (2) 64-72 (1994).
In: Pharmacopeia European, 1997, Chap. 2.2.35, 1997 p. 38.
“Physiologie des Menschen”, R.F. Schmidt, et al., Springer-Verlag, Berlin Heidelberg New York 1980, Table of contents.
“Ultrasound Doppler Measurements of Low Velocity Blood Flow: Limitations Due to Clutter Signals from Vibrating Muscles”. Andreas Heimdal IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 44, No. 4, Jul. 1997.
Levine, Ruth; “Pharmacology: Drug Actions and Reactions”; 6th Edition, Parthenon Publishing, New York, 2000, pp. 102-105.

Affiliated with

Also associated with

Rating

Intravenous pharmaceutical form of administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intravenous pharmaceutical form of administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous pharmaceutical form of administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4229784